Brain

Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting 

CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies

Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the basal...

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting...

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies...

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing...

BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

120 mg and newly announced 60 mg once-daily doses each achieved ≥85% median hsCRP reductions in participants with obesity and...

Vestibular Therapy: Regaining Balance After Dizziness or Concussion Explained in HelloNation Featuring Physical Therapy Expert Jeff Kessler

The article outlines how structured vestibular therapy helps people reduce dizziness, improve stability, and support concussion recovery.BUDD LAKE, NJ., April...

error: Content is protected !!